Clinical and endoscopic analysis of gastric Dieulafoy’s lesion

Table 1 Clinical presentation and endoscopy diagnosis of DL

Patient No.	Sex/age (yr)	Clinical presentation	Hemodynamic instability	Location	Stigmata (forrest)	Diagnosis at initial endoscopy
1	M/40	Melena/hematemesis	+	Subcardinal area (remnant stomach)	Ia	+
2	M/60	Melena/hematemesis	+	Subcardinal area	Ia	+
3	M/36	Melena	-	Fundus	IIa	+
4	F/15	Melena/hematemesis	+	Fundus	Ib	+
5	M/11	Melena/hematemesis	+	Fundus	Ia	+
6	M/20	Hematemesis	+	Proximal corpus	Ia	+
7	F/54	Melena/hematemesis	+	Fundus	Ia	+
8	M/23	Melena/hematemesis	+	Proximal corpus	Ia	-
9	F/43	Melena	-	Fundus	Ia	+
10	F/80	Hypotension	+	Fundus	IIb	-
11	M/25	Melena/hematemesis	+	Fundus	Ia	+
12	M/35	Melena/hematemesis	+	Fundus	Ia	+
13	M/25	Melena/hematemesis	+	Fundus	Ia	-
14	M/47	Melena/hematemesis	+	Fundus	Ia	+
15	M/28	Melena/hematemesis	+	Fundus	Ia	+

Ia: Spurting bleeding; Ib: Oozing bleeding; IIa: Nonbleeding visible vessel; IIb: Minute mucosal defect below an adherent clot. For patients who were not diagnosed with DL during initial endoscopy, the location and stigmata refer to the findings during repeated endoscopy. DL: Dieulafoy’s lesion.

Table 2 Endoscopy treatment and outcome of DL

Patient No.	Endoscopy treatment	Primary hemostasis	Relapse within 30 h	Treatment for relapse	Hemostasis for relapse	Follow-up (mo)
1	EPI + hemoclip	+	-	-	-	22
2	EPI + HP + hemoclip	+	-	-	-	10
3	Hemoclip	+	-	-	-	17
4	EPI	+	-	-	-	33
5	Hemoclip	+	-	-	-	28
6	Hemoclip	+	-	-	-	39
7	Hemoclip	+	-	-	-	6
8	Hemoclip	+	+	Surgery	-	8
9	Hemoclip	+	-	-	-	44
10	-	-	+	2nd: angiography embolism; 3th: hemoclip	+	41
11	Hemoclip	+	+	Angiography embolism	-	-(death)
12	Hemoclip	+	-	-	-	17
13	Hemoclip	+	-	-	-	6
14	Hemoclip	+	-	-	-	35
15	Hemoclip	+	-	-	-	21

EPI: Epinephrine; HP: Heat probe.